2020 (v1)
Publication
Cystic Fibrosis (CF) is caused by mutations (mainly F508del) of the cystic fibrosis transmembrane conductance regulator (CFTR). Current CF therapies are aimed at symptoms alleviation, calling for new drugs to rescue CFTR function. Hypothesis and objectives Drug repositioning is aimed at finding new applications for already marketed drugs,...
Uploaded on: April 14, 2023